Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
about
Lung cancer: epidemiology, etiology, and preventionAt the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of boneInterplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesisEmerging roles of Nrf2 signal in non-small cell lung cancerCombining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancerNon-small cell lung cancer in never smokers: a clinical entity to be identifiedFactors affecting 30-month survival in lung cancer patientsIdentification of feature genes for smoking-related lung adenocarcinoma based on gene expression profile dataGene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival.Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer.Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study.alpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer.Fucoidan inhibition of lung cancer in vivo and in vitro : role of the Smurf2-dependent ubiquitin proteasome pathway in TGFβ receptor degradationChanging trends in the incidence of ovarian neoplasia and its relationship with the risk factors: a report of 311 cases from north-eastern anatolia region.Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on AfatinibPolymorphisms in DNA repair genes of XRCC1, XPA, XPC, XPD and associations with lung cancer risk in Chinese peopleStatistical modeling of lung cancer: answering relative questions.Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study[Diffuse and calcified nodular opacities].Proteomic approaches in lung cancer biomarker development.Uncovering disparities in survival after non-small-cell lung cancer among Asian/Pacific Islander ethnic populations in California.p21-activated kinase 1: PAK'ed with potential.Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.Lung cancer in never smokers.Surgical resection for non-small cell lung cancer: clinical features and outcomes for a consecutive series at an Irish tertiary referral centre.MicroRNAs in human lung cancer.Classification of lung cancer histology by gold nanoparticle sensors.Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation-positive non-small cell lung cancers: an update for recent advances in therapeutics.Lung Cancer in Never Smokers.Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on AfatinibAryl hydrocarbon receptor in association with RelA modulates IL-6 expression in non-smoking lung cancer.Cigarette Smoking and Pancreatic Cancer Survival.An in silico analytical study of lung cancer and smokers datasets from gene expression omnibus (GEO) for prediction of differentially expressed genesEfficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study.Difference in survival and prognostic factors between smokers and never-smokers with advanced non-small-cell lung cancer.Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma.Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.Construction of a 26‑feature gene support vector machine classifier for smoking and non‑smoking lung adenocarcinoma sample classification.Lung cancer in never-smokers - what are the differences?Prognostic factors for survival in a Chinese population presenting with advanced non-small cell lung cancer with an emphasis on smoking status: A regional, single-institution, retrospective analysis of 4552 patients.
P2860
Q24630167-A17C47A8-4A03-41E6-AA55-0D7023FA015FQ26866067-2B5E6ACE-9A8C-42AD-B4EB-77C8B0401E76Q26996794-3E8F2D98-F997-4FB4-AD64-BBBE1D50B025Q28078928-92A34C95-2C9C-4815-8A12-CCEF57624E50Q28388778-C40A6CAC-7F60-4348-8841-A5F4FEA3F7C6Q28393152-746D9AFE-8D5E-4475-97FF-4F816D311112Q28710394-D20AE3D1-9427-4958-A4B6-132DF8A6C6B2Q31150103-4A49C516-AF77-406B-9167-41883E9B11A6Q33320978-5379B3BC-32FF-4519-93B7-61D813AD267EQ33625469-390D09CD-F58F-402E-B081-FC81CA977A4BQ33772389-4CB34C9B-3627-49C7-BF94-904E9F406AC4Q34357105-6A5839BB-ED45-4314-AE05-E5AE1A23E689Q34365917-44AB5699-EA77-445E-85DC-506E114098BAQ35124883-9A1FFB96-3E8B-44FC-845B-CCF55649C971Q35807946-8A4A7301-95A9-4B43-918A-E3880F6548ADQ35894236-87F482E1-C043-484E-BC71-FD09DCA63B8DQ36735627-6EB0CC27-8D0A-44AC-8575-EC73D622532EQ36808416-6820A7BB-27C5-49DA-BAD8-1BBCD9E26629Q37354628-F3A9912F-040C-4193-BD7F-FD79D01FAF9DQ37390661-A7AC9E8A-D8C1-45F2-B7B0-33011746F6A5Q37393760-C5BBC3FA-F9CB-43F6-9D62-D375EBF03422Q37886485-A5FFEFC9-3D1B-4CE6-96FE-5DD12465B408Q37942070-3AE7D92B-2F5F-4002-9012-99F929C2B883Q37944937-FA2CC97E-4F99-4497-B9C0-5CDFD3773754Q38058754-16821B66-2B11-4B79-832C-7A366C9C62F1Q38215733-CC954AC7-D272-4537-B8B4-BB52EAEBF2D7Q38286916-293435F0-723E-4BD2-80E8-281C55C9625CQ38412163-15D99B16-790A-441F-9FB6-7F90EE921EACQ38669269-A654EF76-31E6-430B-902F-C231985E96B8Q39339545-AC2A5512-C0CE-47AF-ABA2-0AB6C3B0D45EQ39458560-80D9FBD1-FA5B-4642-A7E0-64E459728557Q40266936-F82462DE-F594-48EA-928D-E2519730F049Q40783190-4B400660-2385-4D06-88A1-4D35C19DB4D9Q41099007-35B91DE3-B03A-47F6-900F-197355A8158AQ45029897-4E2BEA3C-8964-4046-A3F4-E023832C2106Q45272652-AF733094-0D54-4B9D-AF3D-C2E7E428A61CQ45307428-05EC1847-313E-426E-A340-3AA3ABC25448Q47173515-25A0768A-F9CE-44F4-AB3F-D84A552F216FQ47760940-54D879EE-5DAD-430D-9CC4-3D43F423576EQ50050177-09A99E02-A923-4564-BFE1-3E4C2E13103C
P2860
Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Differences in epidemiology, h ...... op non-small cell lung cancer.
@ast
Differences in epidemiology, h ...... op non-small cell lung cancer.
@en
Differences in epidemiology, h ...... op non-small cell lung cancer.
@nl
type
label
Differences in epidemiology, h ...... op non-small cell lung cancer.
@ast
Differences in epidemiology, h ...... op non-small cell lung cancer.
@en
Differences in epidemiology, h ...... op non-small cell lung cancer.
@nl
prefLabel
Differences in epidemiology, h ...... op non-small cell lung cancer.
@ast
Differences in epidemiology, h ...... op non-small cell lung cancer.
@en
Differences in epidemiology, h ...... op non-small cell lung cancer.
@nl
P356
P1433
P1476
Differences in epidemiology, h ...... lop non-small cell lung cancer
@en
P2093
Ayesha Bryant
Robert James Cerfolio
P304
P356
10.1378/CHEST.07-0442
P407
P577
2007-06-15T00:00:00Z